Abbiss Cadres LLP

PACIRA logo

Pacira Pharmaceutical's first overseas subsidiary in the U.K

As a first step, we obtained a sponsorship license for the newly established English subsidiary company before securing a visa for the first U.S. executive to come to England.

We helped Pacira devise and implement a global mobility policy, from cost of living and expatriate allowances to offering practical help such as organising familiarisation visits to the UK for U.S. executives and their families.

Our specialists dealt with all tax and social security aspects of the assignments, organised home and host country tax briefings, compliance and filings in both jurisdictions on an ongoing basis.

We dealt with UK tax registrations; payroll; organised local benefits provision, including pensions auto-enrolment; salary sacrifice arrangements, the roll out of the company’s stock option, restricted stock and all employee stock purchase plan, and related advice on aspects including tax, social security, financial services regulation, pensions law, and data protection.

https://www.pacira.com/

View company profile

Company details

Incorporated:
20 August 2008
Industry:
Biotechnology and pharmaceuticals
Abbiss Cadres’ unique multi-disciplinary approach has enabled my team to ensure that we hit the ground running in the UK - our first international location. They proved extremely valuable in removing obstacles to delivering an effective set-up for both our UK colleagues and those of our US colleagues who have spearheaded that initiative on assignment. They help us ask the questions we need to ask and to deliver appropriate, practical solutions across the HR piece, whether that requires legal, tax, consulting or operational input. Our good experiences have led us to expand our relationship and retain them to deliver the same approach and its benefits, working with their international colleagues, as we move to enter new markets in Europe and Canada. I am very happy to recommend them.
Rich Kahr Vice President, Human Resources Pacira Pharmaceuticals